Acadia Healthcare Company, Inc. Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2025: 6.20%

Acadia Healthcare Company, Inc. Return on Equity (ROE) is 6.20% for the Trailing 12 Months (TTM) ending March 31, 2025, a -1,648.11% change year over year. Return on equity measures profit against shareholder equity; higher ROE indicates superior profitability and value creation.
  • Acadia Healthcare Company, Inc. Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2024 was -0.40%, a -103.98% change year over year.
  • Acadia Healthcare Company, Inc. Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2023 was 10.07%, a 2.88% change year over year.
  • Acadia Healthcare Company, Inc. Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2022 was 9.78%, a -132.72% change year over year.
  • Acadia Healthcare Company, Inc. Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2021 was -29.91%, a -749.73% change year over year.
Key Data
Date Return on Equity (ROE) Return on Assets (ROA) Revenue Per Share Free Cash Flow Per Share